Back to Search Start Over

Viral loads of parainfluenza virus type 3 and severity of respiratory diseases in children.

Authors :
Ichinose M
Soneda K
Shibata M
Kinoshita K
Ikegawa K
Hataya H
Horikoshi Y
Source :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2023 Jul; Vol. 29 (7), pp. 678-682. Date of Electronic Publication: 2023 Mar 15.
Publication Year :
2023

Abstract

Background: Parainfluenza virus type 3 (PIV-3) is one of the common pathogens for respiratory infections in children. Whether viral load of PIV-3 is associated with severity of respiratory diseases in children is not yet known. Our aim was to determine significance of PIV-3 viral load among infected children.<br />Methods: We conducted a single-center, retrospective study at Tokyo Metropolitan. Children's Medical Center, Japan, from June to August 2021. Hospitalized children were screened with a posterior nasal swab for multiplex PCR, and viral load was subsequently measured from remained samples by real-time PCR. Demographic data were collected from digital charts. PIV-3 positive patients were categorized into mild group with no oxygen demand, moderate group with low-flow oxygen demand and severe group with high-flow nasal cannula oxygen or non-invasive positive pressure ventilation or mechanical ventilation. Viral loads were compared among mild, moderate and severe groups.<br />Results: 151 patients were positive for PIV-3. We found no statistically significant association among PIV-3 viral load and severity of respiratory diseases (p = 0.35), and no statistically significant association between severity of illness and co-detection of other viruses. In each severity group, relatively high viral load per posterior nasal swab was observed at the time of testing.<br />Conclusion: Among PIV-3 patients, we could not find statistically significant between viral load and their severity, therefore we could not conclude that viral load is a good surrogate marker for clinical severity of PIV-3.<br />Competing Interests: Declaration of competing interest None. In conducting the research, we received approval from the hospital's Ethics Committee.<br /> (Copyright © 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1437-7780
Volume :
29
Issue :
7
Database :
MEDLINE
Journal :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Publication Type :
Academic Journal
Accession number :
36925104
Full Text :
https://doi.org/10.1016/j.jiac.2023.03.011